Your weekly roundup of the latest news from Drug Topics®.
Lenacapavir was approved with the FDA's Breakthrough Therapy Designation.
In the midst of an opioid epidemic, CBD may help patients experiencing opioid withdrawal symptoms find relief.
Research tells a different story than recent news headlines.
The Medicare Part D Senior Savings Model—a CMS effort to test $35 copays for insulin—led to lowered total costs for beneficiaries.
The COVID-19 vaccine rate for teenagers lags behind vaccination rates for adults. Does parental hesitancy for vaccines in general play a role?
Read more
Podcast: Discussing the Shared Central Fulfillment Solution with iA
May 6th 2024Brian Nowosielski, associate editor with Drug Topics, sat down with Tom Utech and Reed Richardson of iA, an innovative pharmacy fulfillment company. Utech, CEO of iA, and Richardson, Chief Commercial Officer of iA, discussed the company's new shared central fulfillment solution. The new solution, designed to streamline processes within the pharmacy, is a technological innovation with life-saving benefits for patients.